A 62-year-old with type 2 diabetes (A1c 9.2%) and established ASCVD is on metformin. eGFR is 58 mL/min/1.73 m². According to current standards, what t...

Question

A 62-year-old with type 2 diabetes (A1c 9.2%) and established ASCVD is on metformin. eGFR is 58 mL/min/1.73 m². According to current standards, what therapy should be added for cardiovascular benefit?

Accepted Answer

GLP-1 receptor agonist with proven CV benefit

Answer

Sulfonylurea

Answer

Basal insulin

Answer

Thiazolidinedione

Answer

DPP-4 inhibitor

us-abim MCQ (SBA): Type 2 Diabetes-CV Risk

A 62-year-old with type 2 diabetes (A1c 9.2%) and established ASCVD is on metformin. eGFR is 58 mL/min/1.73 m². According to current standards, what therapy should be added for cardiovascular benefit?